 |
市場調査レポート
商品コード
1441224
DNA合成の世界市場規模、シェア、成長分析、サービスタイプ別、用途別、エンドユーザー別-産業予測、2023～2030年Global DNA Synthesis Market Size, Share, Growth Analysis, By Service Type, By Application, By End-user - Industry Forecast 2023-2030 |
||||||
| DNA合成の世界市場規模、シェア、成長分析、サービスタイプ別、用途別、エンドユーザー別-産業予測、2023～2030年 |
|
出版日: 2024年02月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
DNA合成の世界市場規模は、2022年に29億米ドルと評価され、予測期間（2024～2031年）のCAGRは19.63%で、2023年の34億6,000万米ドルから2031年までに145億3,000万米ドルに成長する展望です。
世界のDNA合成市場は、医薬品、バイオテクノロジー、遺伝学研究など、さまざまなセグメントで重要な役割を担っているため、著しい成長を遂げています。研究者やバイオテクノロジー企業は、医薬品開発から遺伝子操作に至るまで、幅広い用途に合わせたDNA配列を作成するために、DNA合成サービスを利用するようになってきています。この市場の拡大を後押ししているのは、合成生物学ツールに対する需要の高まり、個別化医療の出現、遺伝子編集技術の進歩です。さらに、DNA合成サービスは、研究室での迅速なプロトタイピングと実験を促進し、イノベーションを促進し、科学的ブレークスルーのペースを加速します。バイオテクノロジーと医療のセグメントが進歩を続ける中、DNA合成市場はゲノミクスと分子生物学の軌跡に大きな影響を及ぼす準備が整っています。
目次
エグゼクティブサマリー
- 市場概要
- 転変
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
DNA合成の世界市場：サービスタイプ別
- 市場概要
- 遺伝子合成
- オリゴヌクレオチド合成
DNA合成の世界市場：用途別
- 市場概要
- 研究開発
- 治療
DNA合成の世界市場：エンドユーザー別
- 市場概要
- バイオ医薬品企業
- 学術研究機関
- 受託研究機関
DNA合成の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Thermo Fisher Scientific, Inc.（米国）
- Twist Bioscience（米国）
- Bioneer Corporation（韓国）
- Eton Bioscience（米国）
- LGC Biosearch Technologies（米国）
- IBA GmbH（ドイツ）
- Eurofins Scientific（ルクセンブルグ）
- Integrated DNA Technologies, Inc.（米国）
- Quintara Biosciences（米国）
- GenScript Biotech Corporation（中国）
- Agilent Technologies（米国）
- Merck KGaA（ドイツ）
- Eurogentec（ベルギー）
- Cambio Ltd.（英国）
- Biomatik（カナダ）
Global DNA Synthesis Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.46 Billion in 2023 to USD 14.53 Billion by 2031, at a CAGR of 19.63% during the forecast period (2024-2031).
The global DNA synthesis market is witnessing notable growth owing to its crucial role across various sectors including pharmaceuticals, biotechnology, and genetics research. Researchers and biotech firms are increasingly turning to DNA synthesis services to create tailored DNA sequences for a broad array of applications, spanning from drug development to genetic manipulation. This market's expansion is fuelled by the escalating demand for synthetic biology tools, the emergence of personalized medicine, and the ongoing advancements in gene editing technologies. Furthermore, DNA synthesis services facilitate swift prototyping and experimentation in laboratories, fostering innovation and expediting the pace of scientific breakthroughs. As the biotechnology and healthcare sectors continue to progress, the DNA synthesis market stands ready to exert significant influence on the trajectory of genomics and molecular biology.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global DNA Synthesis and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global DNA Synthesis Market Segmental Analysis
The global DNA synthesis market is segmented on the basis of Service type, Application, End-user, and region. Based on service type the market is segmented as Gene Synthesis, Oligonucleotide Synthesis. On the basis of application, the market is segmented as Research and Development, Therapeutics. Based on end-user, it is segregated into Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global DNA Synthesis Market
One of the primary factors propelling the DNA synthesis market is the ongoing progress in genetic engineering technologies. Breakthroughs such as CRISPR-Cas9 and other gene-editing methods have notably heightened the need for customized DNA sequences, thereby stimulating the expansion of DNA synthesis services. Given the necessity for precise and tailored DNA constructs in their endeavours, researchers and biotech firms consider DNA synthesis an indispensable element of advanced genetic engineering initiatives.
Restraints in the Global DNA Synthesis Market
A significant challenge in the DNA synthesis sector is the strict regulatory landscape. Rigorous regulations and supervision concerning the synthesis and application of genetic materials, particularly in gene editing and biotechnology, can erect obstacles to entering the market and impede research and development endeavours. While these regulations are crucial for ethical and safety considerations, they can present hurdles for businesses operating in this domain.
Market Trends of the Global DNA Synthesis Market
A significant trend in the DNA synthesis sector is the ongoing progress in gene editing technologies, exemplified by CRISPR-Cas9. These advancements are spurring the need for customized DNA sequences, facilitating precise genetic alterations across various domains like therapeutic research and agriculture. With gene editing tools becoming increasingly accessible and adaptable, the DNA synthesis market is positioned for continuous expansion, meeting the changing demands of researchers and biotech entities.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global DNA Synthesis Market by Service Type
- Market Overview
- Gene Synthesis
- Oligonucleotide Synthesis
Global DNA Synthesis Market by Application
- Market Overview
- Research And Development
- Therapeutics
Global DNA Synthesis Market by End-user
- Market Overview
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
Global DNA Synthesis Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Twist Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioneer Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eton Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LGC Biosearch Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IBA GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated DNA Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quintara Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurogentec (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cambio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomatik (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
